closed

Mobile Narcotic Treatment Programs and Medication Units Round Two

Department of Health Care Services · 78705

Eligibility details

Eligible organizations must meet all the following minimum requirements: • The primary NTP must have a valid DHCS license.• The primary NTP must have a valid DEA Registration.• The primary NTP must have a valid Substance Abuse and Mental Health Administration (SAMHSA) accreditation.• The primary NTP must demonstrate Drug Medi-Cal (DMC) enrollment.

Matching funds & resources

Source matching-funds field: Not Required.

Matching funds and leveraged resources are different requirements. Read the description and reviewed rules below before determining resource commitments.

About this opportunity

MUs and MNTPs expand access to medications for opioid use disorder treatment (MOUD, also known as MAT), including buprenorphine, methadone, and naltrexone, to patients unable to travel to an NTP due to lack of geographic proximity or other factors. On June 28, 2021, the U.S. Drug Enforcement Administration (DEA) released new rules allowing DEA-registered Opioid Treatment Programs (NTPs in California) to establish and operate MNTPs without obtaining a separate DEAregistration for each mobile component. As a result, California is spearheading these efforts to increase MUs and MNTPs to increase access to MOUD. On January 8, 2024, DHCS released new guidance related to the creation of MNTPs in California. That guidance is available in BHIN 24-005. The target audience for this opportunity are DHCS-licensed NTPs. All NTPs are encouraged to apply, with priority being given to NTPs wanting to expand their services via an MU and/or an MNTP to prioritize rural communities, correctional facilities, local DHCS-licensed residential substance use disorder facilities that do not offer MAT, and Indigenous and Native communities. NTPs will also be prioritized for serving Medi-Cal beneficiaries. Allowable expenses would include: • The purchase and outfitting of an MNTP;• Costs to establish an MU including securing a lease, renovations, and related equipment;• General maintenance, redesign, and additional startup expenses to comply with DEA and state regulations;• Staffing and recruitment costs, up to 5% of total funds requested; and• Marketing and community engagement activities related to accessing and engaging in services provided by the MU/MNTP, up to 5% of total funds requested. Eligible applicants may choose to apply for two tracks: • Track one: Medication Unit (MU) - For track one, applicants can apply for up to $400,000 per MU. This funding can only be used for initial start-up costs for new medication units and cannot be used for ongoing or established work. Provider organizations may apply for multiple MUs per eligible NTP site, but separate applications are required for each MU requested. • Track two: Mobile Narcotic Treatment Program (MNTP)For track two, applicants can apply for up to $1,000,000 per MNTP. This funding can only be used for initial start-up costs for new mobile units and cannot be used for ongoing costs. Provider organizations may apply for one MNTP per eligible NTP site, but separate applications are required for each MNTP requested. Note: Applicants are required to offer Buprenorphine as well as Methadone as a condition of program participation.

Funding geography: Must be in the State of California.

Funding instrument: Grant. Issuing jurisdiction: California. This is not a geographic eligibility determination.